- Retraction Note
- Open Access
Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7
Stem Cell Research & Therapy volume 13, Article number: 166 (2022)
Retraction Note: Stem Cell Research & Therapy (2021) 12:349 https://doi.org/10.1186/s13287-021-02393-8
The Editors-in-Chief have retracted this article at the request of the Corresponding Author.
After publication, the authors identified flaws in the study design and the data.
Further assessment of the article identified the following issues:
The number of tumor cells inoculated into mice for the xenograft experiment was higher than recommended by internationally accepted standards.
In Fig. 2d, the western blot image backgrounds and empty spaces in lane 1 appear remarkably similar.
In Fig. 6c and d, a number of tumor images appear remarkably similar.
In addition, the authors were unable to locate the original ethics approval documents.
The Editors-in-Chief therefore no longer have confidence in the presented data and the conclusions of this article.
All authors agree to this retraction.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhang, R., Li, P., Lv, H. et al. Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7. Stem Cell Res Ther 13, 166 (2022). https://doi.org/10.1186/s13287-022-02842-y